Skip to content
777 Sourcing.

Capability

CNS-directed AAV9-mediated gene therapy

Suppliers
1
States & provinces
1
Countries
1

1 cns-directed aav9-mediated gene therapy supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

JAYA BIOSCIENCES, INC.

SOUTH SAN FRANCISCO, CA

Jaya Biosciences is a privately held preclinical-stage life sciences company developing CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer's, Parkinson's, and frontotemporal dementia. Its lead therapy JB111 is an experimental CNS-directed AAV9-mediated PPT1 gene therapy being developed for Alzheimer's disease associated with PPT1 haploinsufficiency.

gene therapy developmentpreclinical drug development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list CNS-directed AAV9-mediated gene therapy.

Browse all capabilities